期刊文献+

泉州地区女性人乳头状瘤病毒感染与宫颈病变的相关性探讨 被引量:11

Relationship between human papilloma virus infection and cervical lesion of women in Quanzhou
原文传递
导出
摘要 目的探讨泉州地区女性人乳头状瘤病毒(HPV)的感染率及型别分布特点。方法采用导流杂交基因芯片法对泉州地区4769例女性进行HPV分型检测,其中562例同时做液基细胞学(TCT)检测。结果筛查人群HPV的总感染率为23.6%,感染率最高的型别为HPV16,为26.6%;其次为HPV52、11、58、6、18,分别为18.8%、16.2%、13.4%、12.2%、8.8%;各年龄段HPV的感染率差异有统计学意义(χ2=36.486,P<0.01),82例宫颈癌患者HPV感染率为86.6%,显著高于宫颈炎患者(2χ=110.414,P<0.01)和健康体检者(2χ=157.925,P<0.01);宫颈癌患者HPV感染以HPV16型为主,其次为HPV18型。结论不同人群HPV感染率差异有统计学意义(P<0.01),HPV感染与宫颈病变及宫颈癌的发生密切相关,HPV检测是筛查宫颈癌的有效辅助方法。 OBJECTIVE To investigate the infection rate and subgenotypes distribution of human papilloma virus(HPV) in women of Quanzhou.METHODS A total of 4769 women were checked for 21 subtypes of HPV by flow-through hybridization and gene chip technology.Thinprep Cytology Test was also detected in 562 patients.RESULTS The positive rate of HPV in 4769 women was 23.6%.HPV 16 was the most common type,and the other common types,in descending order of frequency,were 52,11,58,6 and 18,the infection rates of which were in turn 18.8%、16.2%、13.4%、12.2%、8.8%.There was significant difference in HPV positive rates among the investigated age group(χ2=36.486,P0.01).The infection rate of HPV in 82 patients(86.6%) was significantly higher than that in women with cervical erosion(P0.01) or normal healthy women(P0.01).There was a significant difference between cervical erosion group and normal healthy group as well(P0.01).HPV 16 infection was the most common type in cervical cancer patients,accounting for 26.6% followed HPV 18.CONCLUSION The HPV positive rates among different groups are significantly different(P0.01).High risk HPV infection is closely related with the cervical lesion as well as cervical cancer.HPV detection is a valuable technique for cervical cancer screening.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2011年第7期1367-1370,共4页 Chinese Journal of Nosocomiology
基金 福建省青年人才项目(2008F3123) 福建医科大学科技发展专项基金(FZS08004)
关键词 人乳头状瘤病毒 基因亚型 基因芯片 宫颈癌 Human papillomavirus Genotype Gene chips Cervical cancer
  • 相关文献

参考文献9

  • 1zur Hausen H. Papillomaviruses and cancer: from basic stud- ies to clinical applieation[J]. Nat Rev Caneer, 2002,2 (5) : 342-350.
  • 2Munoz N,Bosch FX,Sanjose S,et al Epidemiologic classification ofhuman papillomavirus types associatedwith cervical cancer[J]. N Engl J Med,2003,348(6) :518-527.
  • 3Chan PK, Chang AR, Cheung JL, et al. Determinants of cervical human papillomavirus infection: differences betweenhigh and low-oncogenic risk types[J]. J Infect Dis,2002,185 (1) : 28-35.
  • 4杨英捷,赵健,李雪倩,廖秦平.2285例女性下生殖道人乳头状瘤病毒感染筛查结果分析[J].中国实用妇科与产科杂志,2006,22(6):444-445. 被引量:95
  • 5张东红 林美珊.人乳头瘤病毒在国人宫颈病变中感染及型别分布特征的Meta分析.Chiese General Practice,:1287-1290.
  • 6Beby DA,Bourgoin A,Ragot S,et al. Human papillomavirus infection of the cervixuteri in women attending a health exam-ination center of the French Social Security[J]. J Med Virol, 2004,73(2): 262-268.
  • 7Clifford GM,Smith JS,Plummer M,et al. Human papillomavirus types in invasive cervical cancer worldwide:a meta-analysis[J]. Br J cancer,2003,13,88(1) :63-73.
  • 8贺国丽,郑碧娟,杨舒盈,崔开颖,王雁.200例子宫颈癌患者的HPV感染研究[J].中国妇幼保健,2008,23(30):4299-4300. 被引量:13
  • 9孙丽君,娄雪玲,王东红,杨誉佳.贵州省部分地区妇女宫颈人乳头瘤病毒感染现状调查及分析[J].中国综合临床,2009,25(9):923-927. 被引量:30

二级参考文献35

  • 1陶萍萍,卞美璐,欧华,陈庆云,李敏,刘军.导流杂交基因芯片技术在人乳头状瘤病毒检测中应用的研究[J].中华妇产科杂志,2006,41(1):43-47. 被引量:132
  • 2古扎丽努尔.阿不力孜,程静新,米克热木,古兰丹,李华,米合日尼沙,米日古丽,米日古丽.艾乃土,路玲.新疆维吾尔族妇女宫颈癌的HPV谱研究[J].肿瘤,2007,27(5):379-382. 被引量:48
  • 3Ault KA. Epidemiology and natural history of human papillomavirus infections in the female genital tract[J]. Infect Dis Obstet Gynecol, 2006, Supp1:40470.
  • 4zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application [ J ]. Nat Rev Cancer,2002,2 ( 5 ) : 342-350.
  • 5Syrjanen S, Shabalova IP, Petrovichev N, et al. Human Papillomavirus Testing and Conventional Pap Smear Cytology as Optional Screening Tools of Women at Different Risks for Cervical Cancer in the Countries of the Former Soviet Union [ J ]. J Low Genit Tract Dis,2002,6(2) :97-110.
  • 6Berman NR. Cervical cancer screening today. The role of HPV DNA testing[ J]. Adv Nurse Pract ,2006,14(4 ) :24-29.
  • 7Munoz N, Bosch FX, de Sanjose S,et al. Epidemiologic classification of human papillomavims types associated with cervical cancer [J]. N Engl J Med,2003,348(6) :518-527.
  • 8Clifford GM, Smith JS, Plummer M, et al. Human papillomavims types in invasive cervical cancer worldwide: a meta-analysis[ J]. Br J Cancer,2003,88( 1 ) : 63-73.
  • 9Biedermann K, Dandachi N, Trattner M, et al. Comparison of realtime PCR signal-amplified in situ hybridization and conventional PCR for detection and quantification of human papillomavirus in ar- chival cervical cancer tissue [ J ]. J Clin Microbiol, 2004,42 ( 8 ) : 3758-3765.
  • 10Eiben GL, da Silva DM, Fausch SC, et al. Cervical cancer vaccines: recent advances in HPV research[ J]. Viral Immunol,2003, 16(2) :111-121.

共引文献132

同被引文献121

引证文献11

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部